Drug intelligence / Profile preview

IGNYT

Development stage: Unknown
Lead developer: Adorshea Bioceutics
Modality: Small Molecules
Administration: Oral

Overview

IGNYT is a small molecule nutraceutical product developed by Adorshea Bioceutics, specifically formulated for the management of male sexual dysfunction and male infertility. As a dietary supplement, it is designed to provide metabolic and antioxidant support to improve reproductive health, including sperm count, motility, and morphology. The product is currently approved and marketed in India as part of Adorshea's infertility and sexual health portfolio.

Brand names: IGNYT

Beyond the preview

Go deeper on IGNYT.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IGNYT.

Explore the full profile